Search

Author/Creator Fruchtman, Steven M.

1. A phase 1/2 study of rigosertib in patients with myelodysplastic syndromes (MDS) and MDS progressed to acute myeloid leukemia. (January 2018)

Authors:
Navada, Shyamala C.; Fruchtman, Steven M.; Odchimar-Reissig, Rosalie; Demakos, Erin P.; Petrone, Michael E.; Zbyszewski, Patrick S.; Holland, James F.; Silverman, Lewis R.
Journal:
Leukemia research
Issue:
Volume 64(2018)
Page Start:
10
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Proceedings of the fifth international RASopathies symposium: When development and cancer intersect. Issue 12 (10th October 2018)

Authors:
Rauen, Katherine A.; Schoyer, Lisa; Schill, Lisa; Stronach, Beth; Albeck, John; Andresen, Brage S.; Cavé, Hélène; Ellis, Michelle; Fruchtman, Steven M.; Gelb, Bruce D.; Gibson, Christopher C.; Gripp, Karen; Hefner, Erin; Huang, William Y. C.; Itkin, Maxim; Kerr, Bronwyn; Linardic, Corinne M.; McM...
Journal:
American journal of medical genetics
Issue:
Volume 176:Issue 12(2018)
Page Start:
2924
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Rigosertib in combination with azacitidine in patients with myelodysplastic syndromes or acute myeloid leukemia: Results of a phase 1 study. (July 2020)

Authors:
Navada, Shyamala C.; Garcia-Manero, Guillermo; OdchimarReissig, Rosalie; Pemmaraju, Naveen; Alvarado, Yesid; Ohanian, Maro N.; John, Rosmy B.; Demakos, Erin P.; Zbyszewski, Patrick S.; Maniar, Manoj; Woodman, Richard C.; Fruchtman, Steven M.; Silverman, Lewis R.
Journal:
Leukemia research
Issue:
Volume 94(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗